Epoxy
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
Global Epigenetics Market Research Report 2023
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Epigenetics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 DNA Methylation
1.2.3 Histone Modifications
1.2.4 Others Technologies
1.3 Market by Application
1.3.1 Global Epigenetics Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 Metabolic Diseases
1.3.4 Developmental Biology
1.3.5 Immunology
1.3.6 Cardiovascular Diseases
1.3.7 Others Applications
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Epigenetics Market Perspective (2017-2028)
2.2 Epigenetics Growth Trends by Region
2.2.1 Epigenetics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Epigenetics Historic Market Size by Region (2017-2022)
2.2.3 Epigenetics Forecasted Market Size by Region (2023-2028)
2.3 Epigenetics Market Dynamics
2.3.1 Epigenetics Industry Trends
2.3.2 Epigenetics Market Drivers
2.3.3 Epigenetics Market Challenges
2.3.4 Epigenetics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Epigenetics Players by Revenue
3.1.1 Global Top Epigenetics Players by Revenue (2017-2022)
3.1.2 Global Epigenetics Revenue Market Share by Players (2017-2022)
3.2 Global Epigenetics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Epigenetics Revenue
3.4 Global Epigenetics Market Concentration Ratio
3.4.1 Global Epigenetics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Epigenetics Revenue in 2021
3.5 Epigenetics Key Players Head office and Area Served
3.6 Key Players Epigenetics Product Solution and Service
3.7 Date of Enter into Epigenetics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Epigenetics Breakdown Data by Type
4.1 Global Epigenetics Historic Market Size by Type (2017-2022)
4.2 Global Epigenetics Forecasted Market Size by Type (2023-2028)
5 Epigenetics Breakdown Data by Application
5.1 Global Epigenetics Historic Market Size by Application (2017-2022)
5.2 Global Epigenetics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Epigenetics Market Size (2017-2028)
6.2 North America Epigenetics Market Size by Country (2017-2022)
6.3 North America Epigenetics Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Epigenetics Market Size (2017-2028)
7.2 Europe Epigenetics Market Size by Country (2017-2022)
7.3 Europe Epigenetics Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Epigenetics Market Size (2017-2028)
8.2 Asia-Pacific Epigenetics Market Size by Country (2017-2022)
8.3 Asia-Pacific Epigenetics Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Epigenetics Market Size (2017-2028)
9.2 Latin America Epigenetics Market Size by Country (2017-2022)
9.3 Latin America Epigenetics Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Epigenetics Market Size (2017-2028)
10.2 Middle East & Africa Epigenetics Market Size by Country (2017-2022)
10.3 Middle East & Africa Epigenetics Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 IlluminA
11.1.1 IlluminA Company Detail
11.1.2 IlluminA Business Overview
11.1.3 IlluminA Epigenetics Introduction
11.1.4 IlluminA Revenue in Epigenetics Business (2017-2022)
11.1.5 IlluminA Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Epigenetics Introduction
11.2.4 Thermo Fisher Scientific Revenue in Epigenetics Business (2017-2022)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Merck Millipore
11.3.1 Merck Millipore Company Detail
11.3.2 Merck Millipore Business Overview
11.3.3 Merck Millipore Epigenetics Introduction
11.3.4 Merck Millipore Revenue in Epigenetics Business (2017-2022)
11.3.5 Merck Millipore Recent Development
11.4 Abcam
11.4.1 Abcam Company Detail
11.4.2 Abcam Business Overview
11.4.3 Abcam Epigenetics Introduction
11.4.4 Abcam Revenue in Epigenetics Business (2017-2022)
11.4.5 Abcam Recent Development
11.5 Active Motif
11.5.1 Active Motif Company Detail
11.5.2 Active Motif Business Overview
11.5.3 Active Motif Epigenetics Introduction
11.5.4 Active Motif Revenue in Epigenetics Business (2017-2022)
11.5.5 Active Motif Recent Development
11.6 Bio-Rad
11.6.1 Bio-Rad Company Detail
11.6.2 Bio-Rad Business Overview
11.6.3 Bio-Rad Epigenetics Introduction
11.6.4 Bio-Rad Revenue in Epigenetics Business (2017-2022)
11.6.5 Bio-Rad Recent Development
11.7 New England Biolabs
11.7.1 New England Biolabs Company Detail
11.7.2 New England Biolabs Business Overview
11.7.3 New England Biolabs Epigenetics Introduction
11.7.4 New England Biolabs Revenue in Epigenetics Business (2017-2022)
11.7.5 New England Biolabs Recent Development
11.8 Agilent
11.8.1 Agilent Company Detail
11.8.2 Agilent Business Overview
11.8.3 Agilent Epigenetics Introduction
11.8.4 Agilent Revenue in Epigenetics Business (2017-2022)
11.8.5 Agilent Recent Development
11.9 Qiagen
11.9.1 Qiagen Company Detail
11.9.2 Qiagen Business Overview
11.9.3 Qiagen Epigenetics Introduction
11.9.4 Qiagen Revenue in Epigenetics Business (2017-2022)
11.9.5 Qiagen Recent Development
11.10 Zymo ResearcH
11.10.1 Zymo ResearcH Company Detail
11.10.2 Zymo ResearcH Business Overview
11.10.3 Zymo ResearcH Epigenetics Introduction
11.10.4 Zymo ResearcH Revenue in Epigenetics Business (2017-2022)
11.10.5 Zymo ResearcH Recent Development
11.11 Perkinelmer
11.11.1 Perkinelmer Company Detail
11.11.2 Perkinelmer Business Overview
11.11.3 Perkinelmer Epigenetics Introduction
11.11.4 Perkinelmer Revenue in Epigenetics Business (2017-2022)
11.11.5 Perkinelmer Recent Development
11.12 Diagenode
11.12.1 Diagenode Company Detail
11.12.2 Diagenode Business Overview
11.12.3 Diagenode Epigenetics Introduction
11.12.4 Diagenode Revenue in Epigenetics Business (2017-2022)
11.12.5 Diagenode Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Epigenetics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of DNA Methylation
Table 3. Key Players of Histone Modifications
Table 4. Key Players of Others Technologies
Table 5. Global Epigenetics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Epigenetics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Epigenetics Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Epigenetics Market Share by Region (2017-2022)
Table 9. Global Epigenetics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Epigenetics Market Share by Region (2023-2028)
Table 11. Epigenetics Market Trends
Table 12. Epigenetics Market Drivers
Table 13. Epigenetics Market Challenges
Table 14. Epigenetics Market Restraints
Table 15. Global Epigenetics Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Epigenetics Market Share by Players (2017-2022)
Table 17. Global Top Epigenetics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epigenetics as of 2021)
Table 18. Ranking of Global Top Epigenetics Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Epigenetics Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Epigenetics Product Solution and Service
Table 22. Date of Enter into Epigenetics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Epigenetics Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Epigenetics Revenue Market Share by Type (2017-2022)
Table 26. Global Epigenetics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Epigenetics Revenue Market Share by Type (2023-2028)
Table 28. Global Epigenetics Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Epigenetics Revenue Market Share by Application (2017-2022)
Table 30. Global Epigenetics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Epigenetics Revenue Market Share by Application (2023-2028)
Table 32. North America Epigenetics Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Epigenetics Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Epigenetics Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Epigenetics Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Epigenetics Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Epigenetics Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Epigenetics Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Epigenetics Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Epigenetics Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Epigenetics Market Size by Country (2023-2028) & (US$ Million)
Table 42. IlluminA Company Detail
Table 43. IlluminA Business Overview
Table 44. IlluminA Epigenetics Product
Table 45. IlluminA Revenue in Epigenetics Business (2017-2022) & (US$ Million)
Table 46. IlluminA Recent Development
Table 47. Thermo Fisher Scientific Company Detail
Table 48. Thermo Fisher Scientific Business Overview
Table 49. Thermo Fisher Scientific Epigenetics Product
Table 50. Thermo Fisher Scientific Revenue in Epigenetics Business (2017-2022) & (US$ Million)
Table 51. Thermo Fisher Scientific Recent Development
Table 52. Merck Millipore Company Detail
Table 53. Merck Millipore Business Overview
Table 54. Merck Millipore Epigenetics Product
Table 55. Merck Millipore Revenue in Epigenetics Business (2017-2022) & (US$ Million)
Table 56. Merck Millipore Recent Development
Table 57. Abcam Company Detail
Table 58. Abcam Business Overview
Table 59. Abcam Epigenetics Product
Table 60. Abcam Revenue in Epigenetics Business (2017-2022) & (US$ Million)
Table 61. Abcam Recent Development
Table 62. Active Motif Company Detail
Table 63. Active Motif Business Overview
Table 64. Active Motif Epigenetics Product
Table 65. Active Motif Revenue in Epigenetics Business (2017-2022) & (US$ Million)
Table 66. Active Motif Recent Development
Table 67. Bio-Rad Company Detail
Table 68. Bio-Rad Business Overview
Table 69. Bio-Rad Epigenetics Product
Table 70. Bio-Rad Revenue in Epigenetics Business (2017-2022) & (US$ Million)
Table 71. Bio-Rad Recent Development
Table 72. New England Biolabs Company Detail
Table 73. New England Biolabs Business Overview
Table 74. New England Biolabs Epigenetics Product
Table 75. New England Biolabs Revenue in Epigenetics Business (2017-2022) & (US$ Million)
Table 76. New England Biolabs Recent Development
Table 77. Agilent Company Detail
Table 78. Agilent Business Overview
Table 79. Agilent Epigenetics Product
Table 80. Agilent Revenue in Epigenetics Business (2017-2022) & (US$ Million)
Table 81. Agilent Recent Development
Table 82. Qiagen Company Detail
Table 83. Qiagen Business Overview
Table 84. Qiagen Epigenetics Product
Table 85. Qiagen Revenue in Epigenetics Business (2017-2022) & (US$ Million)
Table 86. Qiagen Recent Development
Table 87. Zymo ResearcH Company Detail
Table 88. Zymo ResearcH Business Overview
Table 89. Zymo ResearcH Epigenetics Product
Table 90. Zymo ResearcH Revenue in Epigenetics Business (2017-2022) & (US$ Million)
Table 91. Zymo ResearcH Recent Development
Table 92. Perkinelmer Company Detail
Table 93. Perkinelmer Business Overview
Table 94. Perkinelmer EpigeneticsProduct
Table 95. Perkinelmer Revenue in Epigenetics Business (2017-2022) & (US$ Million)
Table 96. Perkinelmer Recent Development
Table 97. Diagenode Company Detail
Table 98. Diagenode Business Overview
Table 99. Diagenode EpigeneticsProduct
Table 100. Diagenode Revenue in Epigenetics Business (2017-2022) & (US$ Million)
Table 101. Diagenode Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Epigenetics Market Share by Type: 2021 VS 2028
Figure 2. DNA Methylation Features
Figure 3. Histone Modifications Features
Figure 4. Others Technologies Features
Figure 5. Global Epigenetics Market Share by Application in 2021 & 2028
Figure 6. Oncology Case Studies
Figure 7. Metabolic Diseases Case Studies
Figure 8. Developmental Biology Case Studies
Figure 9. Immunology Case Studies
Figure 10. Cardiovascular Diseases Case Studies
Figure 11. Others Applications Case Studies
Figure 12. Epigenetics Report Years Considered
Figure 13. Global Epigenetics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Epigenetics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Epigenetics Market Share by Region: 2021 VS 2028
Figure 16. Global Epigenetics Market Share by Players in 2021
Figure 17. Global Top Epigenetics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epigenetics as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Epigenetics Revenue in 2021
Figure 19. North America Epigenetics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. North America Epigenetics Market Share by Country (2017-2028)
Figure 21. United States Epigenetics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Epigenetics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Epigenetics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Epigenetics Market Share by Country (2017-2028)
Figure 25. Germany Epigenetics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Epigenetics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Epigenetics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Epigenetics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Epigenetics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Epigenetics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Epigenetics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Epigenetics Market Share by Region (2017-2028)
Figure 33. China Epigenetics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Japan Epigenetics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. South Korea Epigenetics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Southeast Asia Epigenetics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. India Epigenetics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Australia Epigenetics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Epigenetics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Epigenetics Market Share by Country (2017-2028)
Figure 41. Mexico Epigenetics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Brazil Epigenetics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Epigenetics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Middle East & Africa Epigenetics Market Share by Country (2017-2028)
Figure 45. Turkey Epigenetics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Saudi Arabia Epigenetics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. IlluminA Revenue Growth Rate in Epigenetics Business (2017-2022)
Figure 48. Thermo Fisher Scientific Revenue Growth Rate in Epigenetics Business (2017-2022)
Figure 49. Merck Millipore Revenue Growth Rate in Epigenetics Business (2017-2022)
Figure 50. Abcam Revenue Growth Rate in Epigenetics Business (2017-2022)
Figure 51. Active Motif Revenue Growth Rate in Epigenetics Business (2017-2022)
Figure 52. Bio-Rad Revenue Growth Rate in Epigenetics Business (2017-2022)
Figure 53. New England Biolabs Revenue Growth Rate in Epigenetics Business (2017-2022)
Figure 54. Agilent Revenue Growth Rate in Epigenetics Business (2017-2022)
Figure 55. Qiagen Revenue Growth Rate in Epigenetics Business (2017-2022)
Figure 56. Zymo ResearcH Revenue Growth Rate in Epigenetics Business (2017-2022)
Figure 57. Perkinelmer Revenue Growth Rate in Epigenetics Business (2017-2022)
Figure 58. Diagenode Revenue Growth Rate in Epigenetics Business (2017-2022)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
IlluminA Thermo Fisher Scientific Merck Millipore Abcam Active Motif Bio-Rad New England Biolabs Agilent Qiagen Zymo ResearcH Perkinelmer Diagenode